These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3609455)

  • 21. Macrophage disappearance reaction in Rana esculenta induced by specific antigen and rabbit lymphokines.
    Sipka S; Boldogh I; Szilágyi T
    Acta Microbiol Acad Sci Hung; 1977; 24(1):29-31. PubMed ID: 73345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased delayed type hypersensitivity and immunity to tuberculosis].
    Averbakh MM; Gergert VIa; Kliuev VA; Kolodiazhnaia NS; Litvinov VI
    Probl Tuberk; 1972; 50(6):60-4. PubMed ID: 5051130
    [No Abstract]   [Full Text] [Related]  

  • 23. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of lymphokines in regulation of macrophage differentiation.
    Onozaki K; Akagawa KS; Haga S; Miura K; Hashimoto T; Tokunaga T
    Cell Immunol; 1983 Feb; 76(1):129-36. PubMed ID: 6339080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro studies on the mechanism of macrophage migration inhibition in tuberculin sensitivity.
    Heise ER; Han S; Weiser RS
    J Immunol; 1968 Nov; 101(5):1004-15. PubMed ID: 5748594
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrophage migration inhibition as an in vitro correlate of cutaneous delayed skin reaction. II. Investigations on BCG vaccinated guinea pigs.
    Rédei A; Keserü G; Frigyesi A
    Acta Microbiol Acad Sci Hung; 1973; 20(4):275-81. PubMed ID: 4794976
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunity in tuberculosis: a model of cellular immunity].
    Farga V
    Rev Med Chil; 1982 May; 110(5):493-5. PubMed ID: 7163686
    [No Abstract]   [Full Text] [Related]  

  • 30. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis.
    Elias D; Akuffo H; Britton S
    Trans R Soc Trop Med Hyg; 2005 May; 99(5):363-8. PubMed ID: 15780343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The macrophage in tuberculosis.
    Berthrong M
    Bibl Tuberc; 1970; 26():1-27. PubMed ID: 4984113
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)].
    Aoki T
    Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lymphoreticular tissue and antitubercular immunity. I].
    Lenzini L
    Lotta Tuberc; 1971; 41(1):7-50. PubMed ID: 5285814
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of histamine on the development of delayed hypersensitivity reaction in guinea pigs sensitized with BCG bacilli].
    Janaszek W; Maśliński S
    Przegl Dermatol; 1979; 66(4):345-52. PubMed ID: 493561
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison between immunopotency tests and specific active or passive acquired resistance against Mycobacterium tuberculosis in mice induced with three different preparations of BCG pasteur vaccine.
    Brandely M; Hurtrel B; Lagrange PH
    Clin Exp Immunol; 1983 Oct; 54(1):143-50. PubMed ID: 6413106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokine.
    Honda M; Hayashi H
    Am J Pathol; 1982 Aug; 108(2):171-83. PubMed ID: 6765857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative effect of BCG vaccination on sensitivity to typical and atypical tuberculins.
    Crispen RG
    Dev Biol Stand; 1986; 58 ( Pt B)():645-53. PubMed ID: 3609458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.